199 related articles for article (PubMed ID: 28814833)
1. Markers of oxidative/nitrosative stress and inflammation in lung tissue of rats exposed to different intravenous iron compounds.
Toblli JE; Cao G; Giani JF; Dominici FP; Angerosa M
Drug Des Devel Ther; 2017; 11():2251-2263. PubMed ID: 28814833
[TBL] [Abstract][Full Text] [Related]
2. The complex interplay of iron metabolism, reactive oxygen species, and reactive nitrogen species: insights into the potential of various iron therapies to induce oxidative and nitrosative stress.
Koskenkorva-Frank TS; Weiss G; Koppenol WH; Burckhardt S
Free Radic Biol Med; 2013 Dec; 65():1174-1194. PubMed ID: 24036104
[TBL] [Abstract][Full Text] [Related]
3. Nitrosative Stress and Apoptosis by Intravenous Ferumoxytol, Iron Isomaltoside 1000, Iron Dextran, Iron Sucrose, and Ferric Carboxymaltose in a Nonclinical Model.
Toblli JE; Cao G; Giani JF; Dominici FP; Angerosa M
Drug Res (Stuttg); 2015 Jul; 65(7):354-60. PubMed ID: 25050519
[TBL] [Abstract][Full Text] [Related]
4. Intravenous iron sucrose reverses anemia-induced cardiac remodeling, prevents myocardial fibrosis, and improves cardiac function by attenuating oxidative/nitrosative stress and inflammation.
Toblli JE; Cao G; Rivas C; Giani JF; Dominici FP
Int J Cardiol; 2016 Jun; 212():84-91. PubMed ID: 27038710
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of toxicity and oxidative stress induced by intravenous iron isomaltoside 1000 in a nonclinical model.
Toblli JE; Cao G; Oliveri L; Angerosa M
Arzneimittelforschung; 2011; 61(10):553-65. PubMed ID: 22164963
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the extent of oxidative stress induced by intravenous ferumoxytol, ferric carboxymaltose, iron sucrose and iron dextran in a nonclinical model.
Toblli JE; Cao G; Oliveri L; Angerosa M
Arzneimittelforschung; 2011; 61(7):399-410. PubMed ID: 21899208
[TBL] [Abstract][Full Text] [Related]
7. Differences between original intravenous iron sucrose and iron sucrose similar preparations.
Toblli JE; Cao G; Oliveri L; Angerosa M
Arzneimittelforschung; 2009; 59(4):176-90. PubMed ID: 19517894
[TBL] [Abstract][Full Text] [Related]
8. Physico-chemical properties of the new generation IV iron preparations ferumoxytol, iron isomaltoside 1000 and ferric carboxymaltose.
Neiser S; Rentsch D; Dippon U; Kappler A; Weidler PG; Göttlicher J; Steininger R; Wilhelm M; Braitsch M; Funk F; Philipp E; Burckhardt S
Biometals; 2015 Aug; 28(4):615-35. PubMed ID: 25801756
[TBL] [Abstract][Full Text] [Related]
9. Ferrous sulfate, but not iron polymaltose complex, aggravates local and systemic inflammation and oxidative stress in dextran sodium sulfate-induced colitis in rats.
Toblli JE; Cao G; Angerosa M
Drug Des Devel Ther; 2015; 9():2585-97. PubMed ID: 26005335
[TBL] [Abstract][Full Text] [Related]
10. Iron supplementation at high altitudes induces inflammation and oxidative injury to lung tissues in rats.
Salama SA; Omar HA; Maghrabi IA; AlSaeed MS; EL-Tarras AE
Toxicol Appl Pharmacol; 2014 Jan; 274(1):1-6. PubMed ID: 24215938
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular, liver, and renal toxicity associated with an intravenous ferric carboxymaltose similar versus the originator compound.
Toblli JE; Cao G; Rico L; Angerosa M
Drug Des Devel Ther; 2017; 11():3401-3412. PubMed ID: 29238166
[TBL] [Abstract][Full Text] [Related]
12. The effects of iron dextran on the oxidative stress in cardiovascular tissues of rats with chronic renal failure.
Lim CS; Vaziri ND
Kidney Int; 2004 May; 65(5):1802-9. PubMed ID: 15086920
[TBL] [Abstract][Full Text] [Related]
13. The Induction of Oxidative/Nitrosative Stress, Inflammation, and Apoptosis by a Ferric Carboxymaltose Copy Compared to Iron Sucrose in a Non-Clinical Model.
Toblli JE; Cao G; Angerosa M
J Clin Diagn Res; 2015 Dec; 9(12):FF08-12. PubMed ID: 26816915
[TBL] [Abstract][Full Text] [Related]
14. Sinapic acid mitigates gentamicin-induced nephrotoxicity and associated oxidative/nitrosative stress, apoptosis, and inflammation in rats.
Ansari MA; Raish M; Ahmad A; Ahmad SF; Mudassar S; Mohsin K; Shakeel F; Korashy HM; Bakheet SA
Life Sci; 2016 Nov; 165():1-8. PubMed ID: 27664833
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress markers in predicting response to treatment with ferric carboxymaltose in nondialysis chronic kidney disease patients.
Prats M; Font R; García C; Muñoz-Cortés M; Cabré C; Jariod M; Romeu M; Giralt M; Martinez-Vea A
Clin Nephrol; 2014 Jun; 81(6):419-26. PubMed ID: 24691014
[TBL] [Abstract][Full Text] [Related]
16. Acute and sub-acute effect of ferric carboxymaltose on inflammation and adhesion molecules in patients with predialysis chronic renal failure.
Prats M; Font R; García-Ruiz C; Cabré C; Muñoz-Cortés M; Nogués MR; Jariod M; Romeu M; Martínez-Vea A
Nefrologia; 2013; 33(3):355-61. PubMed ID: 23640119
[TBL] [Abstract][Full Text] [Related]
17. Iron and oxidative stress in renal insufficiency.
Lim CS; Vaziri ND
Am J Nephrol; 2004; 24(6):569-75. PubMed ID: 15550752
[TBL] [Abstract][Full Text] [Related]
18. Long-term exposure to crotonaldehyde causes heart and kidney dysfunction through induction of inflammatory and oxidative damage in male Wistar rats.
Zhang B; Li S; Men J; Peng C; Shao H; Zhang Z
Toxicol Mech Methods; 2019 May; 29(4):263-275. PubMed ID: 30426860
[TBL] [Abstract][Full Text] [Related]
19. Effects of iron deficiency anemia and its treatment with iron polymaltose complex in pregnant rats, their fetuses and placentas: oxidative stress markers and pregnancy outcome.
Toblli JE; Cao G; Oliveri L; Angerosa M
Placenta; 2012 Feb; 33(2):81-7. PubMed ID: 22153683
[TBL] [Abstract][Full Text] [Related]
20. Parenteral iron compounds: potent oxidants but mainstays of anemia management in chronic renal disease.
Zager RA
Clin J Am Soc Nephrol; 2006 Sep; 1 Suppl 1():S24-31. PubMed ID: 17699373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
